Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07537933) titled 'Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel Occlusion' on April 12.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).

Primary Sponsor: Shandong Provincial Hospital

Condition: Acute Ischemic Stroke Large-vessel Occlusion Endovascular Treatment

Intervention: Drug: Tirofiban

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: April 2026

Target Sample Size: 344

Countries of Recruitment: China

To know more, visit htt...